Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Calidi Biotherapeutics (CLDI) has provided an update.
Calidi Biotherapeutics, Inc. is set to present its breakthrough systemic enveloped oncolytic virotherapy platform at the Biocom Global Life Science Partnering & Investor Conference. The event, scheduled for February 28, 2024, at 3:00 p.m. PT, will offer insights into the company’s latest advancements. Investors and industry enthusiasts can access detailed information through the presentation slides, which highlight significant strides in the company’s innovative cancer treatment research.
Find detailed analytics on CLDI stock on TipRanks’ Stock Analysis page.